| Serial Number | 79391354 |
| Word Mark | EFESA |
| Filing Date | Friday, December 22, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, December 26, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, January 14, 2025 |
| Goods and Services | Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical agents affecting metabolism; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; medicines for the treatment of cardiovascular and cerebrovascular diseases; pills for dizziness symptoms treatment being pharmaceutical preparations for the treatment of dizziness; biological preparations for medical purposes being biological preparations for the treatment of anemia, kidney disease and kidney disorders; cardiovascular agents for medical purposes; drugs for medical purposes being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; synthetic peptides for pharmaceutical purposes being synthetic peptides for the treatment of anemia, kidney disease and kidney disorders; pharmaceuticals being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; medicines for human purposes being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; anemia treatment medicines that stimulate red blood cell production being pharmaceutical preparations for the treatment of anemia; medicines to stimulate red blood cell production being pharmaceutical preparations for the treatment of anemia; pharmaceutical preparations for treatment of chronic kidney disease and anemia; biological preparations for treatment of anemia; biological preparations to stimulate red blood cell production for veterinary and medical purposes being biological preparations for the treatment of anemia; synthetic peptides for pharmaceutical and anemia treatment purposes being synthetic peptides for the treatment of anemia; synthetic peptides for pharmaceutical and kidney disease treatment purposes being synthetic peptides for the treatment of kidney disease |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Genexine, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Thursday, March 14, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, April 24, 2024 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, July 23, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 23, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, July 24, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, August 8, 2024 | REFUSAL PROCESSED BY MPU |
| Thursday, August 8, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sunday, August 25, 2024 | REFUSAL PROCESSED BY IB |
| Tuesday, November 12, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 12, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 12, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, November 22, 2024 | FINAL REFUSAL WRITTEN |
| Friday, November 22, 2024 | FINAL REFUSAL E-MAILED |
| Friday, November 22, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, December 19, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, December 19, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 19, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 19, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |